EDF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.425800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.794000E-01
Normal-vs-Stage2
4.935600E-01
Normal-vs-Stage3
6.916800E-01
Normal-vs-Stage4
5.132400E-01
Stage1-vs-Stage2
6.353800E-01
Stage1-vs-Stage3
8.513400E-01
Stage1-vs-Stage4
9.367200E-01
Stage2-vs-Stage3
9.282600E-01
Stage2-vs-Stage4
7.670400E-01
Stage3-vs-Stage4
8.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.518200E-01
Normal-vs-AfricanAmerican
6.142000E-01
Normal-vs-Asian
2.572600E-01
Caucasian-vs-AfricanAmerican
7.994600E-01
Caucasian-vs-Asian
1.377440E-01
AfricanAmerican-vs-Asian
2.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.288000E-01
Normal-vs-Female
4.752800E-01
Male-vs-Female
4.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.698400E-01
Normal-vs-Age(41-60Yrs)
4.046000E-01
Normal-vs-Age(61-80Yrs)
4.999000E-01
Normal-vs-Age(81-100Yrs)
2.313600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.991000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.769400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.329200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.165000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.724000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.909400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.681000E-01
Normal-vs-Daily Drinker
2.316600E-01
Normal-vs-Weekly Drinker
5.332200E-01
Normal-vs-Occasional Drinker
3.753600E-01
Normal-vs-Social Drinker
3.131600E-01
Non Drinker-vs-Daily Drinker
3.033500E-02
Non Drinker-vs-Weekly Drinker
4.467600E-01
Non Drinker-vs-Occasional Drinker
3.053000E-01
Non Drinker-vs-Social Drinker
2.796200E-01
Daily Drinker-vs-Weekly Drinker
4.502400E-01
Daily Drinker-vs-Occasional Drinker
2.207800E-01
Daily Drinker-vs-Social Drinker
2.540000E-01
Weekly Drinker-vs-Occasional Drinker
8.499400E-01
Weekly Drinker-vs-Social Drinker
8.715000E-01
Occasional Drinker-vs-Social Drinker
9.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.031000E-01
Normal-vs-Grade 2
2.320400E-01
Normal-vs-Grade 3
3.339000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.068200E-01
Grade 1-vs-Grade 3
2.421400E-01
Grade 1-vs-Grade 4
4.031000E-01
Grade 2-vs-Grade 3
4.282800E-01
Grade 2-vs-Grade 4
2.320400E-01
Grade 3-vs-Grade 4
3.339000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.717000E-01
Normal-vs-NonDiabetic
3.182800E-01
Diabetic-vs-NonDiabetic
1.343040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.430200E-01
Normal-vs-NoPancreatitis
3.995800E-01
Pancreatitis-vs-NoPancreatitis
4.903200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.015800E-01
Normal-vs-N1
5.310400E-01
N0-vs-N1
1.266960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.474000E-01
Normal-vs-TP53-NonMutant
7.404800E-01
TP53-Mutant-vs-TP53-NonMutant
4.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
